M Pathe, J Schwartz. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAdrenergic beta-Antagonists/therapeutic useAdultBetaxololFemaleHemodynamics/drug effectsHumansHypertension/drug therapyKidney/drug effectsMaleMiddle AgedPropanolamines/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsPropanolaminesBetaxolol
Year: 1985 PMID: 2862715
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070